The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer

Background: Programmed death ligand 1 (PD-L1) expression has been shown to predict benefit from anti-PD-1 treatment in several cancers. However, its predictive value in colorectal cancer seems limited. This study was aimed to explore the clinical and biomarker association of programmed death ligand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Wei, Xiao-Li, Wu, Qi-Nian, Chen, Dong-liang, Zeng, Zhao-Lei, Lu, Jia-Bin, Liu, Ze-Xian, Ju, Huai-Qiang, Ren, Chao, Pan, Zhi-Zhong, Wang, Feng-Hua, Xu, Rui-Hua
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277645/
https://ncbi.nlm.nih.gov/pubmed/30519336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27735
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars